Doctor profile · Federal record
Dr. PAUL AANDERUD, D.O.
Dermatology Physician (CMS: DERMATOLOGY) · Student in an Organized Health Care Education/Training Program · CLACKAMAS, OR
- NPI 1255569273
- Accepts Medicare
- MIPS 90.5 / 100 · 2023
- 21 yrs in practice
- Licensed in 2 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
9775 SE SUNNYSIDE RD STE 500
CLACKAMAS, OR 970155724
(503) 654-7546
fax (503) 786-3542
Credentials & registration
- NPI registered
- June 2009 — 17 yrs on file
- Profile last updated
- May 8, 2013
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- Oregon #DO157838 · Michigan #5101018458
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1255569273. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,659
Distinct HCPCS
10
Medicare allowed
$194,793
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,559 | 312 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 685 | 581 | $94 | |
17000 |
Destruction of precancer skin growth, 1 growth | 508 | 412 | $56 | |
17110 |
Destruction of skin growth, 1-14 growths | 301 | 277 | $120 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 142 | 130 | $59 | |
11102 |
Biopsy of related skin growth, first growth | 133 | 125 | $96 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 110 | 110 | $116 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 58 | 12 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 32 | 28 | $133 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 24 | 24 | $76 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 147. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$278
Transactions
8
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $117.88 | |
| Lilly USA, LLC | 3 | $62.60 | |
| Elekta, Inc. | 1 | $50.05 | |
| ABBVIE INC. | 1 | $29.12 | |
| PFIZER INC. | 1 | $18.48 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,192
Patients
688
Total drug cost
$307,775
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 310 | 219 | $3,799 |
| Betamethasone Dipropionate | Generic | 283 | 156 | $13,174 |
| Doxycycline Hyclate | Generic | 146 | 53 | $3,682 |
| Prednisone | Generic | 106 | 63 | $491 |
| Clobetasol Propionate | Generic | 59 | 38 | $2,736 |
| Fluconazole | Generic | 39 | 17 | $647 |
| Hydroxyzine Hcl | Generic | 36 | 15 | $226 |
| Cephalexin | Generic | 33 | 30 | $156 |
| Ketoconazole | Generic | 28 | 18 | $830 |
| Nystatin | Generic | 28 | 11 | $377 |